Clinical Trial Update: Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating interferon-alpha as maintenance therapy in favorable-risk acute myeloid leukemia, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: RECRUITING